|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Current assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Marketable securities | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Long-term marketable securities | |||||||||||||
| Property and equipment, net | |||||||||||||
| Right-of-use asset, net | |||||||||||||
| Other non-current assets | |||||||||||||
| Total assets | |||||||||||||
| Liabilities and stockholders' equity | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable | |||||||||||||
| Lease liability | |||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||
| Total current liabilities | |||||||||||||
| Long-term liabilities: | |||||||||||||
| Lease liability, net of current | |||||||||||||
| Revenue share liability | |||||||||||||
| Total liabilities | |||||||||||||
| Stockholders' equity: | |||||||||||||
| Common Stock; $0.00001 par value, 400,000,000 authorized, 75,611,894 issued and 75,339,499 outstanding as of June 30, 2026; 400,000,000 authorized, 69,038,943 issued and 68,401,349 outstanding as of December 31, 2025 | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated other comprehensive (loss) income | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total stockholders' equity | |||||||||||||
| Total liabilities and stockholders' equity | |||||||||||||
Loading...
